Cell name:
SU-DHL-4
Cell information:
Cell: Lymphoid neoplasm B-NHL (DLBCL, diffuse large cell, cleaved cell type; originally described as "diffuse histiocytic lymphoma"; carries EZH2 Y641S mutation; assigned to GCB-like lymphoma subtype [germinal center B-cell]).
Model information:
1X107 SU-DHL-4 cells per mouse are mixed with Matri-gel and inoculated into right flank region in CB17 SCID mice.
About 15 days post inoculation, the mice can be grouped, with average tumor volumes at 150-250 m3.
The duration of treatment is about 20 days post grouping (when the tumor volumes in the vehicle group reach 2000 m3).
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059